Abstract
During the last years significant efforts have been made to discover compounds with inhibitory activity of quorum-sensing systems, which could represent an anti-pathogenic strategy, since they will inhibit the coordinated expression of virulence determinants, without interfering with bacterial growth, being less likely to generate resistance. The present study is reviewing the main types of quorum sensing inhibitors known to date, that manifest the potential to be used as anti-virulence drugs for the treatment of infections with multidrug resistant P. aeruginosa strains, and describes a new strategy of virulence attenuation based on organic acids produced by probiotic strains, which have been proved to influence in sub-inhibitory (sI) grown concentrations the QS genes expression in P. aeruginosa multidrug resistant strains, proving that the organic acids secreted by probiotics could act as quorum sensing inhibitors.
Keywords: Anti-pathogenic strategy, Multidrug resistance, Quorum-sensing inhibitors, P. aeruginosa, probiotics
Current Organic Chemistry
Title:Anti-pathogenic Strategies for Fighting Pseudomonas aeruginosa Infections- probiotic Soluble Compounds as Inhibitors of Quorum Sensing Genes Expression
Volume: 17 Issue: 2
Author(s): Ani Ioana Cotar, Crina Saviuc, Roxana Andreea Nita, Eugenia Bezirtzoglou, Veronica Lazar and Mariana Carmen Chifiriuc
Affiliation:
Keywords: Anti-pathogenic strategy, Multidrug resistance, Quorum-sensing inhibitors, P. aeruginosa, probiotics
Abstract: During the last years significant efforts have been made to discover compounds with inhibitory activity of quorum-sensing systems, which could represent an anti-pathogenic strategy, since they will inhibit the coordinated expression of virulence determinants, without interfering with bacterial growth, being less likely to generate resistance. The present study is reviewing the main types of quorum sensing inhibitors known to date, that manifest the potential to be used as anti-virulence drugs for the treatment of infections with multidrug resistant P. aeruginosa strains, and describes a new strategy of virulence attenuation based on organic acids produced by probiotic strains, which have been proved to influence in sub-inhibitory (sI) grown concentrations the QS genes expression in P. aeruginosa multidrug resistant strains, proving that the organic acids secreted by probiotics could act as quorum sensing inhibitors.
Export Options
About this article
Cite this article as:
Ioana Cotar Ani, Saviuc Crina, Andreea Nita Roxana, Bezirtzoglou Eugenia, Lazar Veronica and Carmen Chifiriuc Mariana, Anti-pathogenic Strategies for Fighting Pseudomonas aeruginosa Infections- probiotic Soluble Compounds as Inhibitors of Quorum Sensing Genes Expression, Current Organic Chemistry 2013; 17 (2) . https://dx.doi.org/10.2174/1385272811317020012
DOI https://dx.doi.org/10.2174/1385272811317020012 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pompe Disease: From New Views on Pathophysiology to Innovative Therapeutic Strategies
Current Pharmaceutical Biotechnology The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Some Aspects on Comparative Efficacy Studies with Inhaled Corticosteroids in Asthma
Current Drug Therapy Overview of Angiogenesis and the use of Bevacizumab in Patients with Malignant Gliomas
Current Signal Transduction Therapy Recent Trends in the Design, Synthesis and Biological Exploration of β-Lactams
Current Medicinal Chemistry The Effect of SEX/Gender on Cardiovascular Pharmacology
Current Pharmaceutical Design Recombinant Protein Based Therapeutics for IPF
Inflammation & Allergy - Drug Targets (Discontinued) TGF-β: Its Role in Asthma and Therapeutic Potential
Current Drug Targets Salutary Properties of YC-1 in the Cardiovascular and Hematological Systems
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Endothelial Dysfunction in Diabetes: The Role of Protein Kinase C
Vascular Disease Prevention (Discontinued) Approaching Neurological Diseases to Reduce Mobility Limitations in Older Persons
Current Pharmaceutical Design The Perils, Pitfalls and Opportunities of Using High Sensitivity Cardiac Troponin
Current Medicinal Chemistry Editorial [Hot Topic: Nitric Oxide and Hydrogen Sulfide - Contribution of Gaseous Messengers to the Cardiovascular Control (Guest Editor: Sona Cacanyiova)]
Current Pharmaceutical Biotechnology Left Ventricular Non-compaction: From Recognition to Treatment
Current Pharmaceutical Design Transthyretin and the Systemic Inflammatory Response
Current Nutrition & Food Science The Role of Exhaled Nitric Oxide in the Diagnosis, Management and Treatment of Asthma
Mini-Reviews in Medicinal Chemistry Retinoic Acid and Iron Metabolism: A Step Towards Design of a Novel Antitubercular Drug
Current Pharmaceutical Biotechnology Randomized Clinical Stroke Trials in 2006
Current Vascular Pharmacology Obesity and Body Composition in Man and Woman: Associated Diseases and the New Role of Gut Microbiota
Current Medicinal Chemistry High Throughput Metabolomics in Clinical Studies: Review and New Applications to Remote Ischemic Preconditioning
Current Topics in Medicinal Chemistry